The Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Science Research Council (EPSRC) and Medical Research Council (MRC) are establishing a £25M UK Regenerative Medicine Platform (UKRMP) to address the technical and scientific challenges associated with translating promising scientific discoveries in this area towards clinical impact.
As part of the first stage in the establishment of the UKRMP, four interdisciplinary and complementary research Hubs have been established which together provide a world-leading programme to promote the development of regenerative therapies.
- Cell behaviour, differentiation and manufacturing Hub
- Stem cell niche Hub – engineering and exploiting the niche
- Safety and efficacy Hub – focussing on imaging technologies
- Acellular (smart material) approaches for therapeutic delivery Hub
Each of the Hubs provides a UK centre of expertise/knowledge with the necessary critical mass to address key translational challenges and provide new tools, protocols and resources with broad applicability that can be utilised by other UK research groups in academia and industry.
The Hubs provide a cornerstone of the broader UK research strategy in this area, which is seeking to support high quality UK research activity and translational activity that will help deliver the great promise of regenerative medicine to the benefit of both patients and future economic growth. More information on the Hubs can be found here.
Friday, November 22, 2013
Professor Cay Kielty, University of Manchester has been awarded funding for a Centre for Doctoral Training in Regenerative Medicine, which […]More »
Tuesday, October 8, 2013
The Intention to Apply (I2A) deadline for the Stage II UK Regenerative Medicine Platform – Call for Disease/Systems focussed programmes […]More »
Monday, September 9, 2013
Three UK Research Councils are to invest £25m in research and equipment to support the development of regenerative medicine therapies […]More »